TP53 and breast ductal adenocarcinoma: The significantly higher serum p53 level in BC patients is in line with previous studies reporting the presence of p53 in 30–69% of cases of ductal carcinoma of the breast, with a significant correlation between the p53 overexpression and histological grades of BC as well as with Bcl-267–71.